{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T03:53:23Z","timestamp":1775966003121,"version":"3.50.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/ppo.0000000000000201","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T21:49:58Z","timestamp":1469137798000},"page":"296-301","source":"Crossref","is-referenced-by-count":13,"title":["Stereotactic Body Radiotherapy for Hepatocellular Carcinoma"],"prefix":"10.1097","volume":"22","author":[{"given":"Andrew J.","family":"McPartlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-10-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"R4-10-20210203","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/bjs.7583","article-title":"Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria","volume":"98","author":"Fan","year":"2011","journal-title":"Br J Surg"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ajg.2011.425","article-title":"Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors","volume":"107","author":"Shiina","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jvir.2011.07.002","article-title":"Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma","volume":"22","author":"Sacco","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"R9-10-20210203","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"R10-10-20210203","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":". Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"R11-10-20210203","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jamcollsurg.2012.02.022","article-title":"Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent outcomes","volume":"215","author":"Doyle","year":"2012","journal-title":"J Am Coll Surg"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.sla.0000118373.31781.f2","article-title":"Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients","volume":"239","author":"Curley","year":"2004","journal-title":"Ann Surg"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1148\/radiol.2343040153","article-title":"Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver","volume":"234","author":"Lu","year":"2005","journal-title":"Radiology"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"R16-10-20210203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2006-941442","article-title":"Complications of hepatic chemoembolization","volume":"23","author":"Clark","year":"2006","journal-title":"Semin Intervent Radiol"},{"key":"R17-10-20210203","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/bjc.2014.199","article-title":"Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma","volume":"111","author":"Golfieri","year":"2014","journal-title":"Br J Cancer"},{"key":"R18-10-20210203","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","article-title":"Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies","volume":"23","author":"Ben-Josef","year":"2005","journal-title":"J Clin Oncol"},{"key":"R21-10-20210203","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/02841869509127197","article-title":"Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients","volume":"34","author":"Blomgren","year":"1995","journal-title":"Acta Oncol"},{"key":"R22-10-20210203","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/cncr.27533","article-title":"Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization","volume":"118","author":"Kang","year":"2012","journal-title":"Cancer"},{"key":"R23-10-20210203","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/0284186X.2013.820342","article-title":"Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients","volume":"53","author":"Sanuki","year":"2014","journal-title":"Acta Oncol"},{"key":"R24-10-20210203","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"R25-10-20210203","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.prro.2015.02.007","article-title":"Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1\u20132 trial of stereotactic body radiation therapy","volume":"5","author":"Lasley","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"R26-10-20210203","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2014.05.002","article-title":"Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma","volume":"111","author":"Culleton","year":"2014","journal-title":"Radiother Oncol"},{"key":"R27-10-20210203","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/02841860600897934","article-title":"Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I\u2013II study","volume":"45","author":"Mendez Romero","year":"2006","journal-title":"Acta Oncol"},{"key":"R28-10-20210203","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00432-015-1929-y","article-title":"The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT)","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"R29-10-20210203","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jrr\/rru130","article-title":"Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma","volume":"56","author":"Yamashita","year":"2015","journal-title":"J Radiat Res"},{"key":"R30-10-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2015.04.006","article-title":"Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma","volume":"115","author":"Huertas","year":"2015","journal-title":"Radiother Oncol"},{"key":"R31-10-20210203","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/jgh.12350","article-title":"Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma","volume":"29","author":"Takeda","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"R32-10-20210203","doi-asserted-by":"crossref","first-page":"e63864","DOI":"10.1371\/journal.pone.0063864","article-title":"Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and\/or inferior vena cava tumor thrombosis","volume":"8","author":"Xi","year":"2013","journal-title":"PLoS One"},{"key":"R33-10-20210203","doi-asserted-by":"crossref","first-page":"e79854","DOI":"10.1371\/journal.pone.0079854","article-title":"Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma","volume":"8","author":"Yoon","year":"2013","journal-title":"PLoS One"},{"key":"R34-10-20210203","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1748-717X-8-250","article-title":"High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma","volume":"8","author":"Jang","year":"2013","journal-title":"Radiat Oncol"},{"key":"R35-10-20210203","doi-asserted-by":"crossref","first-page":"e77472","DOI":"10.1371\/journal.pone.0077472","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity","volume":"8","author":"Bibault","year":"2013","journal-title":"PLoS One"},{"key":"R36-10-20210203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijrobp.2011.11.058","article-title":"Stereotactic body radiation therapy in recurrent hepatocellular carcinoma","volume":"84","author":"Huang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R37-10-20210203","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/j.ijrobp.2011.04.011","article-title":"Stereotactic body radiotherapy for primary hepatocellular carcinoma","volume":"81","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R38-10-20210203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jso.21593","article-title":"Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma","volume":"102","author":"Seo","year":"2010","journal-title":"J Surg Oncol"},{"key":"R39-10-20210203","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/153303461000900506","article-title":"Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results","volume":"9","author":"Louis","year":"2010","journal-title":"Technol Cancer Res Treat"},{"key":"R40-10-20210203","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/1471-2407-10-475","article-title":"Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer","volume":"10","author":"Kwon","year":"2010","journal-title":"BMC Cancer"},{"key":"R41-10-20210203","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jjco\/hyi236","article-title":"Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma","volume":"36","author":"Choi","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"R42-10-20210203","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","article-title":"Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma","volume":"34","author":"Wahl","year":"2016","journal-title":"J Clin Oncol"},{"key":"R43-10-20210203","first-page":"1527","article-title":"Comparative research on the efficacy of CyberKnife(R) and surgical excision for Stage I hepatocellular carcinoma","volume":"6","author":"Yuan","year":"2013","journal-title":"Oncol Targets Ther"},{"key":"R44-10-20210203","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/jlts.2002.34892","article-title":"Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria","volume":"8","author":"Yao","year":"2002","journal-title":"Liver Transpl"},{"key":"R45-10-20210203","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijrobp.2011.08.032","article-title":"Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation","volume":"83","author":"Katz","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R46-10-20210203","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jgh.12087","article-title":"Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma","volume":"28","author":"Honda","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R47-10-20210203","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2009.07.1725","article-title":"Angiogenic blockade and radiotherapy in hepatocellular carcinoma","volume":"78","author":"Chi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R48-10-20210203","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.ijrobp.2014.01.017","article-title":"Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma","volume":"88","author":"Chen","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:22:30Z","timestamp":1620969750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130404-201607000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0000000000000201","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}